Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Reimbursement D ...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback